RecallDepth
Class III Terminated

Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.

This recall has been terminated (originally issued June 3, 2020).

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
May 26, 2020
Posted
June 3, 2020
Recall Number
D-1281-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,313,333 tablets
Firm Location
Salisbury, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.

Distribution

TN

Lot / Code Info

Lot #s 19P0437 & 19P0438, Exp. 09/30/2021.

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls